Atara Biotherapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Atara Biotherapeutics (NASDAQ:ATRA) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.67. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. The company's shares are currently trading at $2.3, down 51.92% over the last 52-week period.
August 07, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Atara Biotherapeutics is expected to report an EPS of $-0.67. The company's history of missing EPS estimates and the subsequent negative impact on its share price could potentially influence investor sentiment.
Atara Biotherapeutics has a history of missing EPS estimates, which has led to significant drops in its share price. Given this trend and the analysts' estimate of a negative EPS, it is likely that the company's share price may be negatively impacted in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100